Watson, Apotex Settle Azilect Patent Infringement Suit
A New Jersey federal judge on Thursday dismissed Teva Pharmaceutical Industries Ltd.'s claims that generic-drug makers Watson Laboratories Inc. and Apotex Corp. infringed its patents for the Parkinson's disease drug Azilect,...To view the full article, register now.
Already a subscriber? Click here to view full article